Weight Loss

Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them they've eaten enough. This fascinating discovery could play a big role in the future of weight loss treatments for humans.

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of people who were diabetic before the surgery, meant that they didn’t require diabetes medication five years after.

There's a growing body of evidence that gold nanoparticles can trigger significant weight loss that targets fat, without affecting muscles, plus heal organs and improve blood-glucose levels. A new study makes a strong case for the first-ever human trial.

A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone produced by the hypothalamus during sleep has a direct impact on appetite regulation and metabolism.

As the new year arrives, many will consider going on a diet to shed holiday weight. One popular approach might be intermittent fasting, but a new study says you might want to think twice if having a full head of hair is important to you.

We’re encouraged to drink more water because ‘it’s good for us.’ Now, a new study has tested that claim, examining the evidence from previous studies to see whether increasing the amount of water you drink really does provide health benefits.

If you've ever used a nutrition app or kept a food diary to track calories, you'll know just how cumbersome the process can be. That's where the first automated food-logging wearable comes in, gathering all the data without any of the effort from you.

Balloons that trick the stomach into feeling full have long been used for weight loss. But, they become less effective the longer they stay inflated. Engineers have devised a balloon that inflates and deflates on demand – it reduced food intake by 60%.

An innovative mix of readily available natural products shapes up as a long-term alternative to the likes of Ozempic for managing obesity, diabetes, liver health and inflammation – without the injections, cost or side effects associated with GLP-1 drugs.

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. The popularity of newer weight-loss drugs that shed pounds quickly has raised concerns among researchers about how this will affect the health of our muscles.

The race is on to deliver the first once-a-day weight-loss pill that would be both cheaper and less invasive than the current injectable drugs, with strong results from Terns following those from competitors Eli Lilly, Pfizer, Roche and Structure.